Company profile for GL Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

G.L. Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and is looking back at a history of more than 70 years. We develop, produce and allocate unique brand name products as well as generics for the well-being of people in Austria and abroad. As a supplier to Austria’s healthcare sector, we partner with general practitioners, pharmacists, their patients and pharmaceutical wholesalers. ...
G.L. Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and is looking back at a history of more than 70 years. We develop, produce and allocate unique brand name products as well as generics for the well-being of people in Austria and abroad. As a supplier to Austria’s healthcare sector, we partner with general practitioners, pharmacists, their patients and pharmaceutical wholesalers. As an international player, we market our products through our licensees and branch offices to more than 50 countries.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Austria
Address
Address
Schlossplatz 1, 8502 Lannach
Telephone
Telephone
+43 3136 82577
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/skoreas-gl-rapha-certified-produce-sputnik-covid-19-vaccines-2021-10-26/

Anton Zverev REUTERS
26 Oct 2021

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-gl-pharma-gmbh-oxylan-40mg-prolonged-release-tablets-el-20-a-41#:~:text=Guidance%20and%20support-,Class%202%20Medicines%20Recall%3A%20GL%20Pharma%20GmbH%2C%20Oxylan%2040mg%20prolonged,dissolution%20during%20routine%20stability%20testing.

GOV.UK
01 Sep 2020

https://www.newsdistinct.com/potential-impact-of-coronavirus-outbreak-on-frovatriptan-market-by-product-analysis-2019-2026/

NEWSDISTINCT
28 May 2020

http://fastserviceentree.nl/2020/06/01/impact-van-covid-19-op-dihydrocodene-market-global-industry-groei-op-fabrikanten-regio-product-types-major-application-analysis-and-forecast-naar-2026/

FASTSERVICEENTREE
28 May 2020

https://3wnews.org/uncategorised/679732/assessing-the-fallout-from-the-coronavirus-pandemic-frovatriptan-market-key-players-analysis-2019-2031/

3WNEWS
26 May 2020

https://3wnews.org/industry/739647/frovatriptan-market-overview-industry-demand-development-and-growth-forecast-report-2026/

3WNEWS
07 May 2020

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty